Competitive Intelligence Intern

The internship with Lilly's Competitive Intelligence team (LCCI) provides an excellent opportunity to work with global CI & analytics experts, focusing on gathering and interpreting data from various sources to support portfolio decisions and strategic insights. Interns will engage in intelligence gathering, data visualization, report generation, and contribute to decision-making processes across therapeutic areas. Key Responsibilities: Competitive Intelligence Surveillance Scout and analyze secondary data sources (open/subscription-based) to identify >90% of relevant updates from the competitive environment. Reports and Landscape Analysis Contribute to the creation of Ad-hoc Reports, Target Reports (TR), and Disease Landscapes (DL) through structured data scouting under team guidance. Conference Monitoring Assist in developing conference agendas and timely upload of content for stakeholder access. IR Call Shadowing Observe Investor Relations (IR) calls and manage document uploads to internal platforms like SharePoint. Database Management Maintain and regularly update target and disease landscape databases to support informed decision-making. Data Visualization Use Excel and PowerPoint to present data clearly. Ability to interpret clinical and scientific data accurately is essential. Industry Knowledge Understand fundamental concepts of drug development, clinical trials, and pharmaceutical R&D. Attention to Detail Ensure all data collection, processing, and reporting tasks are completed accurately and on schedule.

Eli Lilly and Company is a global pharmaceutical leader headquartered in Indianapolis, Indiana, USA. Founded in 1876, Lilly is dedicated to discovering, developing, and delivering innovative medicines that improve the lives of people around the world. The company's mission centers on making life better for people globally through breakthrough therapies in areas such as diabetes, oncology, immunology, neuroscience, and more. With over 39,000 employees worldwide, Lilly operates in more than 120 countries and maintains a strong commitment to scientific excellence and patient care. Lilly is recognized for its pioneering work in insulin and diabetes care, as well as for developing widely used medications such as Prozac and Trulicity. In recent years, the company has gained significant attention for its advancements in obesity and diabetes treatments, particularly with the launch of Mounjaro (tirzepatide), which has shown promising results for both type 2 diabetes and weight management. Lilly's robust research pipeline and strategic investments have solidified its reputation as one of the most innovative and respected pharmaceutical companies globally.